CELLIPSE is a drug discovery company based in Grenoble, France dedicated to bringing innovative therapies to cancer patients and healthcare professionals. We are building a pipeline of small molecules targeting the cytoskeleton (i.e. microtubules and actin filaments) based on our « cell to drug discovery » approach.
Looking for a particular CELLIPSE employee's phone or email?
The CELLIPSE annual revenue was $400000 in 2026.
CELLIPSE is based in Grenoble, Auvergne-Rhone-Alpes.
The NAICS codes for CELLIPSE are [3254, 54, 32, 325, 541, 32541].
The SIC codes for CELLIPSE are [28, 2834, 283].